| Net Cash Provided by (Used in) Operating Activities |
$5,884,277 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$680,271 |
USD |
238% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,475,446 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,580,000,000 |
shares |
5.3% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
743,042,911 |
shares |
6.1% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$8,039,994 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$31,302,604 |
USD |
281% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$11,840,576 |
USD |
26% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$11,840,576 |
USD |
26% |
Q4 2024 |
FY 2024 |
| Depreciation |
$16,834 |
USD |
28% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$3,864 |
USD |
28% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$194,052 |
USD |
7.9% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$5,924,165 |
USD |
8.6% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
519,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$106,873,654 |
USD |
18% |
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$11,137,620 |
USD |
-4.8% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |